Exposing plasmids as the Achilles' heel of drug-resistant bacteria.
Many multidrug-resistant bacterial pathogens harbor large plasmids that encode proteins conferring resistance to antibiotics. Although the acquisition of these plasmids often enables bacteria to survive in the presence of antibiotics, it is possible that plasmids also represent a vulnerability that can be exploited in tailored antibacterial therapy. This review highlights three recently described strategies designed to specifically combat bacteria harboring such plasmids: inhibition of plasmid conjugation, inhibition of plasmid replication, and exploitation of plasmid-encoded toxin-antitoxin systems.
Williams
Julia J
JJ
Department of Microbiology, Roger Adams Laboratory, University of Illinois, Urbana, IL 61801, USA.
Hergenrother
Paul J
PJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000992:Antitoxins / Q000276:immunology / Q000378:metabolism; D001419:Bacteria / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D001427:Bacterial Toxins / Q000276:immunology / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D006801:Humans; D010957:Plasmids / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000992:Antitoxins; D001427:Bacterial Toxins